A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

L Lai, C; N Chien, R; W Leung, N; T Chang, T; Guan, R; I Tai, D; Y Ng, K; C Wu, P; C Dent, J; Barber, J; L Stephenson, S; F Gray, D

doi:10.1056/nejm199807093390201

Public

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Shared by NobleBlocks on Jul 9, 1998 • 12:00 AM UTC

Authors:

C L Lai

R N Chien

N W Leung

Abstract

BACKGROUND AND METHODS: In preliminary trials, lamivudine, an oral nucleoside analogue, has shown promise for the treatment of chronic hepatitis B. We conducted a one-year, double-blind trial of lamivudine in 358 Chinese patients with chronic hepatitis B. The patients were randomly assigned to recei...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!